EUVIMEDEUVIMED entdecken
Crossref

Tailoring therapy in Waldenström Macroglobulinemia

Diego Villa

Canadian Hematology Today · 2022

DOI: 10.58931/cht.2022.1212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Hematology Today, 2022. Verfasst von Diego Villa. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Waldenström Macroglobulinemia (WM) is a mature B-cell neoplasm categorized as a lymphoplasmacytic lymphoma (LPL) with monoclonal immunoglobulin M (IgM) production. WM comprises a spectrum of clinical manifestations related to (a) excessive infiltration of the bone marrow and/or other organs (lymph nodes, spleen, extranodal organs) by the LPL infiltrate, and (b) the impact of excess IgM on the circulatory and immune systems, and end organs. The latter includes serum hyperviscosity, infection related to suppression of other immunoglobulins, autoimmune cytopenias, cryoglobulinemia, production of anti-myelin-associated glycoprotein antibodies leading to peripheral neuropathy, and occasionally AL amyloidosis with end-organ deposition.

Zitieren

APA

Villa, D. (2022). Tailoring therapy in Waldenström Macroglobulinemia. Canadian Hematology Today. https://doi.org/10.58931/cht.2022.1212

Vancouver

Villa D. Tailoring therapy in Waldenström Macroglobulinemia. Canadian Hematology Today. 2022. doi:10.58931/cht.2022.1212

BibTeX
@article{Villa2022,
  author = {Villa, Diego},
  title = {Tailoring therapy in Waldenström Macroglobulinemia},
  journal = {Canadian Hematology Today},
  year = {2022},
  doi = {10.58931/cht.2022.1212}
}
Kostenlos starten →